Loading…
S. 3677119th CongressIn committeeLatest action Jan 15, 2026Decoded by AI · checked against the record
Official title: Dietary Supplement Listing Act of 2026
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
Senate bill S 3677 would require dietary supplement makers to register every product with the FDA before it can legally be sold.
50-second read · 4 questions answered below
This bill would require companies that make, package, or distribute dietary supplements to register each product with the FDA and submit details such as ingredients, serving sizes, directions, allergen warnings, and a copy of the label. Products already on shelves would have 18 months to comply; new products must be registered before going on sale. Companies must also update the FDA within 30 days of a label change and within one year of stopping sales of a product.
This bill directly affects dietary supplement manufacturers, distributors, and packagers. Consumers, healthcare providers, and researchers who want accurate information about supplement contents are also affected.
A supplement that is not properly registered would be considered misbranded and could be treated as an illegal product. The FDA would be required to maintain a publicly searchable online database of registered products, though some details such as owner contact information and exact amounts within proprietary blends would remain confidential.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S259-260)